Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings [Yahoo! Finance]
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: Yahoo! Finance
In the last reported quarter, the company's adjusted loss per share of 27 cents was narrower than the Zacks Consensus Estimate of a loss of 31 cents per share. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on all occasions, delivering an earnings surprise of 13.1%, on average. Let's see how things have shaped up prior to this announcement. Factors at Play Last month, PacBio announced preliminary revenues for first-quarter 2024. Per the preliminary report, first-quarter 2024 total revenues are estimated to be $38.8 million, down 0.3% year over year. Per management, the preliminary revenues for the first quarter were below the company's expectations due to an increasing number of customers delaying instrument purchases and softness in consumable shipments. Management also stated that all regions underperformed, with 13 Revio systems falling out of the forecast in the last two weeks of the first quarter. PacBio believes this primarily re
Show less
Read more
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- Reasons to Retain PacBio (PACB) Stock in Your Portfolio [Yahoo! Finance]Yahoo! Finance
- Pacific Biosciences of California, Inc. (PACB) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]Yahoo! Finance
- Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Morgan Stanley from $10.00 to $4.00. They now have an "equal weight" rating on the stock.MarketBeat
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases [Yahoo! Finance]Yahoo! Finance
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare DiseasesPR Newswire
PACB
Earnings
- 5/9/24 - In-Line
PACB
Sec Filings
- 5/30/24 - Form SD
- 5/30/24 - Form DEFA14A
- 5/22/24 - Form 4
- PACB's page on the SEC website